Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TADALAFIL USP, with a corresponding US DMF Number 27479.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 25, 2014, and payment made on September 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II